MariMed Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-14.5M | $-12.5M | $-16.0M | $13.5M | $7.2M | $2.1M | $-81.2M | $-13.6M |
| Depreciation & Amortization | $8.1M | $7.9M | $5.5M | $3.4M | — | $1.8M | $1.0M | $658.0K |
| Depreciation | $8.1M | $7.9M | $5.5M | $3.4M | $2.1M | $1.8M | $999.1K | $657.9K |
| Amortization | $3.4M | $2.9M | $3.0M | $1.3M | $690.0K | $390.5K | $197.5K | — |
| Stock-Based Compensation | $1.9M | $1.1M | $1.0M | $6.3M | — | — | — | $5.8M |
| Net Cash from Operating Activities | $7.7M | $6.8M | $7.9M | $7.3M | $35.9M | $3.4M | $-24.1M | $-2.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.2M | $12.0M | $20.1M | $12.1M | $17.9M | $4.7M | $9.7M | $8.9M |
| Business Acquisitions | $-231.0K | $4.3M | $3.0M | $12.8M | $0 | — | $211.8K | $-13.5K |
| Net Cash from Investing Activities | $-1.4M | $-17.1M | $-26.0M | $-26.2M | $-16.6M | $-4.5M | $-12.5M | $-40.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-4.7M | $3.0M | $23.0M | $-1.0M | $7.5M | $3.3M | $33.3M | $45.8M |
| Net Change in Cash | $1.6M | $-7.4M | $4.9M | $-19.9M | $26.7M | $2.3M | $-3.4M | $2.8M |
| Free Cash Flow | $6.5M | $-5.2M | $-12.2M | $-4.8M | $18.0M | $-1.3M | $-33.8M | $-11.8M |